Regeneron Pharmaceuticals Inc. (REGN)

374.26
NASDAQ : Health Technology
Prev Close 371.78
Day Low/High 370.17 / 377.86
52 Wk Low/High 281.89 / 505.49
Avg Volume 781.70K
Exchange NASDAQ
Shares Outstanding 106.14M
Market Cap 40.17B
EPS 11.30
P/E Ratio 26.94
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Bluebird Bio And Regeneron Announce Collaboration To Discover, Develop And Commercialize New Cell Therapies For Cancer

Bluebird Bio And Regeneron Announce Collaboration To Discover, Develop And Commercialize New Cell Therapies For Cancer

bluebird bio, Inc. (NASDAQ: BLUE) and Regeneron Pharmaceuticals, Inc.

Regeneron Soars After My 'Go Long' Recommendation: What Now?

Regeneron Soars After My 'Go Long' Recommendation: What Now?

An updated strategy for the high-flying REGN.

How to Invest at Every Age: Cramer's 'Mad Money' Recap (Thursday 7/26/18)

How to Invest at Every Age: Cramer's 'Mad Money' Recap (Thursday 7/26/18)

Jim Cramer looks at the investment strategies you and your family need to employ throughout your life.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMD, ARII, GLW, NEP, REGN, UHAL Downgrades: ASTE, GEC, SINO, SXT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Regeneron Pharmaceuticals Takes Over #154 Spot From Kimberly-Clark Corp.

Regeneron Pharmaceuticals Takes Over #154 Spot From Kimberly-Clark Corp.

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Regeneron Pharmaceuticals, Inc. has taken over the #154 spot from Kimberly-Clark Corp.

How to Invest at Every Age: Cramer's 'Mad Money' Recap (Tuesday 6/26/18)

How to Invest at Every Age: Cramer's 'Mad Money' Recap (Tuesday 6/26/18)

Jim Cramer looks at the investment strategies you and your family need to employ throughout your life.

Kraft Heinz, VF Corp, Cimarex Energy: 'Mad Money' Lightning Round

Kraft Heinz, VF Corp, Cimarex Energy: 'Mad Money' Lightning Round

Jim Cramer takes a look at Kraft Heinz, VF Corp, Cimarex Energy, STORE Capital, Wheaton Precious Metals, Bluebird Bio, First Commonwealth Financial Corp.

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Jim Cramer says many stocks already reflect the worst-case scenarios, and that means he sees a lot of upside potential.

Regeneron Is Leading the Way for Biotech

Regeneron Is Leading the Way for Biotech

Recent action tells us REGN's momentum is super strong.

Chart of the Day: Regeneron

Wednesday’s action tells us REGN’s momentum is super strong.

Regeneron Pharmaceuticals Becomes #47 Most Shorted Nasdaq 100 Component, Replacing Texas Instruments

Regeneron Pharmaceuticals Becomes #47 Most Shorted Nasdaq 100 Component, Replacing Texas Instruments

The most recent short interest data has been released for the 05/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Regeneron And Zoetis Announce Collaboration To Research Antibody Therapies For Use In Animal Health

Regeneron And Zoetis Announce Collaboration To Research Antibody Therapies For Use In Animal Health

Collaboration will also generate preclinical data to inform Regeneron's development of human medicines

Nasdaq's on Fire: Cramer's 'Mad Money' Recap (Monday 6/4/18)

Nasdaq's on Fire: Cramer's 'Mad Money' Recap (Monday 6/4/18)

Jim Cramer talks about the stocks and sectors behind the resurgence fueling the Nasdaq's gains.

Jim Cramer: Move Over FANG, Long Live INJFANG

Jim Cramer: Move Over FANG, Long Live INJFANG

The Nasdaq hit an all-time high today, and It's Not Just FANG anymore.

Aggressive Traders Must Go Long Regeneron Pharmaceuticals

Aggressive Traders Must Go Long Regeneron Pharmaceuticals

We have more evidence to support the bull case.

Box, American Outdoor Brands, Lululemon: 'Mad Money' Lightning Round

Box, American Outdoor Brands, Lululemon: 'Mad Money' Lightning Round

Cramer weighs in on Box, American Outdoor Brands, Lululemon Athletica, Henry Schein, Regeneron Pharmeceuticals, Opko Health and more.

Trade Wars Rock Stocks: Cramer's 'Mad Money' Recap (Thursday 5/31/18)

Trade Wars Rock Stocks: Cramer's 'Mad Money' Recap (Thursday 5/31/18)

Jim Cramer says these tariffs aren't that big, but this selloff is entirely rational.

Regeneron's Investigational Ebola Treatment Shipping To Democratic Republic Of The Congo For Use In Current Outbreak

TARRYTOWN, New York, May 31, 2018 /PRNewswire/ -- Regeneron working with World Health Organization, U.

Regeneron Downtrend Ending But No Rush to Buy

Regeneron Downtrend Ending But No Rush to Buy

Stock still needs a period of base building to support advance.

Stealth Rally: Cramer's 'Mad Money' Recap (Thursday 5/10/18)

Stealth Rally: Cramer's 'Mad Money' Recap (Thursday 5/10/18)

Take one part great earnings and one part tremendous skepticism, add in low inflation and you end up with this astonishing stealth rally. Jim Cramer explains it.

Regeneron Pharmaceuticals Becomes #32 Most Shorted Nasdaq 100 Component, Replacing Citrix Systems

The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B- (Buy)